Partner diagnostic and pathology solutions, under one accountable partner.
Aiforia digital pathology AI and Algoscope surgery-to-pathology workflow automation — represented, clinically positioned, and locally supported by Translyx across New Zealand and Oceania.
Partner products
Digital pathology AI & workflow automation
Represented by Translyx in New Zealand — not Translyx-owned products.
Authorised partner solution
Aiforia Digital Pathology AI
AI-assisted digital pathology workflows for clinical, preclinical, and research applications — including Aiforia Clinical Suites and Aiforia Create Platform.
Explore AiforiaPartner product
Algoscope
AI-powered workflow automation and traceability across surgery-to-pathology pathways — computer vision, 3D modelling, and pre-analytical workflow intelligence for operating rooms and pathology laboratories.
Explore AlgoscopeExplore the Translyx pipeline
Capabilities under evaluation & diagnostic innovation
Governed clinical AI workflow capabilities in evaluation and development, plus diagnostic innovation across AMR, sepsis, point-of-care testing, oncology, endocrine, cardiac, and precision medicine. Pipeline capabilities are not launched products.
One company. A governed bridge between global innovation and local clinical adoption.
Translyx connects partner digital pathology AI, governed clinical AI workflow capabilities, and a diagnostic innovation pipeline — under one accountable, New Zealand-based partner.
Clinical technology partner
Translyx Limited
Auckland, New Zealand · Oceania
Aiforia and Algoscope are partner products represented by Translyx in New Zealand — not Translyx-owned products. Pipeline capabilities are under evaluation or development and are not publicly launched products.
Speak with Translyx about your clinical technology priorities.
Request a walkthrough to see Aiforia digital pathology AI, Algoscope workflow automation, and the broader Translyx pipeline in context.